Cargando…
High G2 and S‐phase expressed 1 expression promotes acral melanoma progression and correlates with poor clinical prognosis
G2 and S‐phase expressed 1 (GTSE1) regulates cell cycle progression in human cancers. However, its significance and mechanism of action in acral melanoma (AM) remain unknown. In the present study, we found that GTSE1 expression was upregulated in advanced stage/metastatic AM tissues and metastatic c...
Autores principales: | Xu, Tianxiao, Ma, Meng, Chi, Zhihong, Si, Lu, Sheng, Xinan, Cui, Chuanliang, Dai, Jie, Yu, Sifan, Yan, Junya, Yu, Huan, Wu, Xiaowen, Tang, Huan, Yu, Jiayi, Kong, Yan, Guo, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5989838/ https://www.ncbi.nlm.nih.gov/pubmed/29660787 http://dx.doi.org/10.1111/cas.13607 |
Ejemplares similares
-
Increased AURKA Gene Copy Number Correlates with Poor Prognosis and Predicts the Efficacy of High-dose Interferon Therapy in Acral Melanoma
por: Yan, Junya, et al.
Publicado: (2018) -
TERT copy gain predicts the outcome of high-dose interferon α-2b therapy in acral melanoma
por: Yu, Sifan, et al.
Publicado: (2018) -
Systemic Immune-Inflammation Index and Circulating T-Cell Immune Index Predict Outcomes in High-Risk Acral Melanoma Patients Treated with High-Dose Interferon
por: Yu, Jiayi, et al.
Publicado: (2017) -
Mutations in BRAF codons 594 and 596 predict good prognosis in melanoma
por: Wu, Xiaowen, et al.
Publicado: (2017) -
Anti-GD2/4-1BB chimeric antigen receptor T cell therapy for the treatment of Chinese melanoma patients
por: Yu, Jiayi, et al.
Publicado: (2018)